Cultural characteristics and antibiotic susceptibility pattern of Helicobacter Pylori isolated from dyspepsia patients

被引:7
作者
Adeniyi, Bolanle A. [1 ]
Lawal, Temitope O. [1 ]
Otegbayo, Jesse A. [2 ]
Oluwasola, Olayiwola A. [3 ]
Odaibo, Georgina N. [4 ]
Ola, Samuel O. [2 ]
Okolo, Clement A. [3 ]
Akere, Adegboyega [2 ]
Kehinde, Aderemi O. [5 ]
机构
[1] Univ Ibadan, Dept Pharmaceut Microbiol, Ibadan, Nigeria
[2] Univ Ibadan, Dept Med, Ibadan, Nigeria
[3] Univ Ibadan, Dept Pathol, Ibadan, Nigeria
[4] Univ Ibadan, Dept Virol, Ibadan, Nigeria
[5] Univ Ibadan, Dept Med Microbiol, Ibadan, Nigeria
关键词
Helicobacter pylori; cultural characteristics; antibiotics susceptibility pattern; multi;
D O I
10.4081/gi.2012.e21
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Helicobacter pylori consist in a helical shaped Gram-negative bacterium, approximately 3 micrometers long with a diameter of approximately 0.5 micrometers. It has 4-6 flagella. It is microaerophilic and tests positive for oxidase, catalase and urease. With its flagella, the bacterium moves through the stomach lumen and drills into the mucus gel layer of the stomach. In humans, H. pylori have been associated with peptic ulcers, chronic gastritis, duodenitis and stomach cancer. It is widely believed that in the absence of treatment, H. pylori infection, once established in its gastric niche, persists for life. The aim of this research is to study the cultural characteristics and antibiotic susceptibility pattern of H. pylori strains isolated from southwest Nigeria. The cultural characteristics and antibiotic susceptibility pattern of Helicobacter pylori strains isolated from gastric mucosal antral biopsy specimens collected from 43 of 52 dyspepsia patients in the University College Hospital Ibadan, Oyo State, Nigeria, were determined using standard microbiological methods for Helicobacter pylori isolation. The 43 isolates were subjected to 23 different antibiotics and each of the antibiotics demonstrated a variable degree of activity against the isolates. Among the antibiotics to which the organism was most susceptible are: ofloxacin (30 mu g) 100% activity, ciprofloxacin (5 mu g) 97.67% activity, gentamicin (120 mu g) 95.35 activity, amikacin (30 mu g), kanamycin (30 mu g) and chloramphenicol (30 mu g) each 90.70% activity, clarithromycin (15 mu g) 93.02, while the less active antibiotics are: augmentin (30 mu g) 23.26% active, amoxycillin (25 mu g) and metronidazole (50 mu g) each 27.91% active and clindamycin (2 mg) 30.23% active. From the result of the antibiotic susceptibility pattern of the strains of the organism, 95.35% of the total isolates are multi drug resistant. Resistance was developed to, among others, augmentin (30 mu g), amoxycillin (25 mu g), metronidazole (50 mu g) and clindamycin (2 mg).
引用
收藏
页码:87 / 89
页数:3
相关论文
共 17 条
[1]  
CAYLA R, 1994, GASTROENTEROLOGY, V106, pA61
[2]   Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States [J].
Duck, WM ;
Sobel, J ;
Pruckler, JM ;
Song, OS ;
Swerdlow, D ;
Friedman, C ;
Sulka, A ;
Swaminathan, B ;
Taylor, T ;
Hoekstra, M ;
Griffin, P ;
Smoot, D ;
Peek, R ;
Metz, DC ;
Bloom, PB ;
Goldschmid, S ;
Parsonnet, J ;
Triadafilopoulos, G ;
Perez-Perez, GI ;
Vakil, N ;
Ernst, P ;
Czinn, S ;
Dunne, D ;
Gold, BD .
EMERGING INFECTIOUS DISEASES, 2004, 10 (06) :1088-1094
[3]  
European Helicobacter pylori Study group, 2006, CURR CONC MAN H PYL
[4]   Meta-analysis:: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori [J].
Fischbach, L. ;
Evans, E. L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) :343-357
[5]   Helicobacter pylori and antimicrobial resistance:: molecular mechanisms and clinical implications [J].
Gerrits, Monique M. ;
van Vilet, Arnoud H. M. ;
Kuipers, Ernst J. ;
Kusters, Johannes G. .
LANCET INFECTIOUS DISEASES, 2006, 6 (11) :699-709
[6]   European Multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori [J].
Glupczynski, Y ;
Mégraud, F ;
Lopez-Brea, M ;
Andersen, LP .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (11) :820-823
[7]  
Goodman K, 2001, MED J AUSTRALIA, V151, P431
[8]   Dynamics of Helicobacter pylori infection in a US-Mexico cohort during the first two years of life [J].
Goodman, KJ ;
O'Rourke, K ;
Day, RS ;
Wang, C ;
Nurgalieva, Z ;
Phillips, CV ;
Aragaki, C ;
Campos, A ;
de la Rosa, JM .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2005, 34 (06) :1348-1355
[9]   Eradication of Helicobacter pylori with triple therapy:: An epidetniologic analysis of trends in turkey over 10 years [J].
Kadaylfci, Abdurrahman ;
Buyukhatipoglu, Hakan ;
Savas, M. Cemil ;
Simsek, Ilkay .
CLINICAL THERAPEUTICS, 2006, 28 (11) :1960-1966
[10]  
Megraud F. H., 2007, GUT, V56, P1374